Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Rui Huang, Xiwen Liao & Qiaochuan Li. (2018) Identification of key pathways and genes in TP53 mutation acute myeloid leukemia: evidence from bioinformatics analysis. OncoTargets and Therapy 11, pages 163-173.
Read now
Read now
Meenakshi Mehrotra, Rajyalakshmi Luthra, Farhad Ravandi, Rachel L. Sargent, Bedia A. Barkoh, Ronald Abraham, Bal Mukund Mishra, L. Jeffrey Medeiros & Keyur P. Patel. (2014) Identification of clinically important chromosomal aberrations in acute myeloid leukemia by array-based comparative genomic hybridization. Leukemia & Lymphoma 55:11, pages 2538-2548.
Read now
Read now
Wan-Jen Hong & Bruno C Medeiros. (2011) Unfavorable-risk cytogenetics in acute myeloid leukemia. Expert Review of Hematology 4:2, pages 173-184.
Read now
Read now
Esbjörn Paul, Esbjörn Paul, Bertil Uggla, Stefan Deneberg, Sofia Bengtzen, Monica Hermansson, Ingrid Dahlman, Richard Rosenquist, Klas G. Wiman & Hareth Nahi. (2009) Low p14ARF expression in de novo acute myeloid leukemia with normal karyotype is associated with poor survival. Leukemia & Lymphoma 50:9, pages 1512-1518.
Read now
Read now
Anders Wahlin. (2008) Accumulating evidence for a role of p53 in multiple drug resistant Acute Myeloid Leukemia. Leukemia & Lymphoma 49:3, pages 383-384.
Read now
Read now
Articles from other publishers (21)
Nan Xu, Yue‐Yun Lai, Wen‐Min Chen, Hao Jiang, Yu Wang, Xu Wang, Xiao‐Su Zhao, Xiao‐Jun Huang, Qian Jiang & Ya‐Zhen Qin. (2022)
Independent prognostic significance of
TP53
mutations in adult acute myeloid leukaemia with complex karyotype
. International Journal of Laboratory Hematology 44:5, pages 892-899.
Crossref
Crossref
Daisuke Ikeda, SungGi Chi, Satoshi Uchiyama, Hirotaka Nakamura, Yong-Mei Guo, Nobuhiko Yamauchi, Junichiro Yuda & Yosuke Minami. (2022) Molecular Classification and Overcoming Therapy Resistance for Acute Myeloid Leukemia with Adverse Genetic Factors. International Journal of Molecular Sciences 23:11, pages 5950.
Crossref
Crossref
María Paula Meléndez-Flórez, Duvan Sebastián Valbuena, Sebastián Cepeda, Nelson Rangel, Maribel Forero-Castro, María Martínez-Agüero & Milena Rondón-Lagos. (2022) Profile of Chromosomal Alterations, Chromosomal Instability and Clonal Heterogeneity in Colombian Farmers Exposed to Pesticides. Frontiers in Genetics 13.
Crossref
Crossref
Youjin Wang, Weiyin Zhou, Lisa J. McReynolds, Hormuzd A. Katki, Elizabeth A. Griffiths, Swapna Thota, Mitchell J. Machiela, Meredith Yeager, Philip McCarthy, Marcelo Pasquini, Junke Wang, Ezgi Karaesmen, Abbas Rizvi, Leah Preus, Hancong Tang, Yiwen Wang, Loreall Pooler, Xin Sheng, Christopher A. Haiman, David Van Den Berg, Stephen R. Spellman, Tao Wang, Michelle Kuxhausen, Stephen J. Chanock, Stephanie J. Lee, Theresa E. Hahn, Lara E. Sucheston-Campbell & Shahinaz M. Gadalla. (2021) Prognostic impact of pre-transplant chromosomal aberrations in peripheral blood of patients undergoing unrelated donor hematopoietic cell transplant for acute myeloid leukemia. Scientific Reports 11:1.
Crossref
Crossref
Matteo Molica, Carla Mazzone, Pasquale Niscola & Paolo de Fabritiis. (2021) TP53 Mutations in Acute Myeloid Leukemia: Still a Daunting Challenge?. Frontiers in Oncology 10.
Crossref
Crossref
Raphael Itzykson, Marco Cerrano & Jordi Esteve. 2021. Acute Myeloid Leukemia. Acute Myeloid Leukemia
127
175
.
Iván Martín, Blanca Navarro, Alicia Serrano, Eva Villamón, Marisa Calabuig, Carlos Solano, Felipe Javier Chaves, Nuria Yagüe, Maribel Orts, Paula Amat, Azahara Fuentes, Enrique Seda, Francisca García, Juan Carlos Hernández-Boluda & Mar Tormo. (2020) Impact of clinical features, cytogenetics, genetic mutations, and methylation dynamics of CDKN2B and DLC-1 promoters on treatment response to azacitidine. Annals of Hematology 99:3, pages 527-537.
Crossref
Crossref
A Quintás-Cardama, C Hu, A Qutub, Y H Qiu, X Zhang, S M Post, N Zhang, K Coombes & S M Kornblau. (2016) p53 pathway dysfunction is highly prevalent in acute myeloid leukemia independent of TP53 mutational status. Leukemia 31:6, pages 1296-1305.
Crossref
Crossref
Tapan M. Kadia, Preetesh Jain, Farhad Ravandi, Guillermo Garcia-Manero, Michael Andreef, Koichi Takahashi, Gautam Borthakur, Elias Jabbour, Marina Konopleva, Naval G. Daver, Courtney Dinardo, Sherry Pierce, Rashmi Kanagal-Shamanna, Keyur Patel, Zeev Estrov, Jorge Cortes & Hagop M. Kantarjian. (2016)
TP53
mutations in newly diagnosed acute myeloid leukemia: Clinicomolecular characteristics, response to therapy, and outcomes
. Cancer 122:22, pages 3484-3491.
Crossref
Crossref
Aziz Nazha, Hagop M. Kantarjian, Vijaya R. Bhatt, Graciela Nogueras-Gonzalez, Jorge E. Cortes, Tapan Kadia, Guillermo Garcia-Manero, Lynne Abruzzo, Naval Daver, Naveen Pemmaraju, Alfonso Quintas-Cardama, Farhad Ravandi, Michael Keating & Gautam Borthakur. (2014) Prognostic Implications of Chromosome 17 Abnormalities in the Context of Monosomal Karyotype in Patients With Acute Myeloid Leukemia and Complex Cytogenetics. Clinical Lymphoma Myeloma and Leukemia 14:2, pages 163-171.
Crossref
Crossref
Simon Blechman Zeichner, Sarah Alghamdi, Gina Elhammady, Robert John Poppiti & Amilcar Castellano-Sanchez. (2014) Prognostic Significance of TP53 Mutations and Single Nucleotide Polymorphisms in Acute Myeloid Leukemia: A case Series and Literature Review. Asian Pacific Journal of Cancer Prevention 15:4, pages 1603-1609.
Crossref
Crossref
Brigitte Mohr, Johannes Schetelig, Kerstin Schäfer‐Eckart, Norbert Schmitz, Mathias Hänel, Wolf Rösler, Norbert Frickhofen, Hartmut Link, Andreas Neubauer, Ulrich Schuler, Uwe Platzbecker, Jan M. Middeke, Gerhard Ehninger, Martin Bornhäuser, Markus Schaich & Friedrich Stölzel. (2013) Impact of allogeneic haematopoietic stem cell transplantation in patients with abnl(17p) acute myeloid leukaemia. British Journal of Haematology 161:2, pages 237-244.
Crossref
Crossref
H. Nahi, M. Remberger, M. Machaczka, J. Ungerstedt, J. Mattson, O. Ringden, Katarina Le-Blanc, P. Ljungman & H. Hägglund. (2012) Different impact of intermediate and unfavourable cytogenetics at the time of diagnosis on outcome of de novo AML after allo-SCT: a long-term retrospective analysis from a single institution. Medical Oncology 29:4, pages 2348-2358.
Crossref
Crossref
Timothy S. PardeeEvan GomesJamie Jennings-Gee, David Caudell & William H. Gmeiner. (2012) Unique dual targeting of thymidylate synthase and topoisomerase1 by FdUMP[10] results in high efficacy against AML and low toxicity. Blood 119:15, pages 3561-3570.
Crossref
Crossref
Takashi Asai, Yan Liu, Narae Bae & Stephen D. Nimer. (2011) The p53 tumor suppressor protein regulates hematopoietic stem cell fate. Journal of Cellular Physiology 226:9, pages 2215-2221.
Crossref
Crossref
H. Nahi, T. Sutlu, M. Jansson, E. Alici & G. Gahrton. (2011) Clinical impact of chromosomal aberrations in multiple myeloma. Journal of Internal Medicine 269:2, pages 137-147.
Crossref
Crossref
Juan Carlos Herrera, Luis Fernando Isaza, José Luis Ramírez, Gonzalo Vásquez & Carlos Mario Muñetón. (2010) Detección de aneuploidías del cromosoma 17 y deleción del gen TP53 en una amplia variedad de tumores sólidos mediante hibridación in situ fluorescente bicolor. Biomédica 30:3, pages 390.
Crossref
Crossref
Zhen Zhao, Johannes Zuber, Ernesto Diaz-Flores, Laura Lintault, Scott C. Kogan, Kevin Shannon & Scott W. Lowe. (2010) p53 loss promotes acute myeloid leukemia by enabling aberrant self-renewal. Genes & Development 24:13, pages 1389-1402.
Crossref
Crossref
Anissa M. JabbourCarmel P. DauntBenjamin D. GreenSandra VogelLavinia GordonRachel S. Lee, Natasha SilkeRichard B. Pearson, Cassandra J. Vandenberg, Priscilla N. Kelly, Stephen L. Nutt, Andreas Strasser, Christoph BornerPaul G. Ekert. (2010) Myeloid progenitor cells lacking p53 exhibit delayed up-regulation of Puma and prolonged survival after cytokine deprivation. Blood 115:2, pages 344-352.
Crossref
Crossref
H Seifert, B Mohr, C Thiede, U Oelschlägel, U Schäkel, T Illmer, S Soucek, G Ehninger & M Schaich. (2009) The prognostic impact of 17p (p53) deletion in 2272 adults with acute myeloid leukemia. Leukemia 23:4, pages 656-663.
Crossref
Crossref
Jasmine C. Wong, Michelle M. Le Beau & Kevin Shannon. (2008) Tumor suppressor gene inactivation in myeloid malignancies. Best Practice & Research Clinical Haematology 21:4, pages 601-614.
Crossref
Crossref